Contour™ SureDrive™ M0061458670Recalls & reported problems
Boston Scientific Corporation · Steerable Ureteral Stent Set · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729903222), received between Feb 3, 2023 and Jan 16, 2026 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Detachment of Device or Device Component1
- Device Contamination with Chemical or Other Material1
- Difficult to Remove1
Patient problems
- Hemorrhage/Blood Loss/Bleeding1
- Micturition Urgency1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 16, 2026Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT A CONTOUR URETERAL STENT WAS USED STENT PLACEMENT PROCEDURE IN THE BLADDER AND URETHRA. DURING PROCEDURE CLOSURE, IT WAS NOTICED THAT THERE WERE ORANGE PIECES FROM THE PUSHER. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH THIS DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24103099 ↗MalfunctionAug 7, 2025Difficult to Remove; Detachment of Device or Device Component; Adverse Event Without Identified Device or Use Problem; Difficult to Remove; Detachment of Device or Device Component; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A CONTOUR URETERAL STENT WAS IMPLANTED INTO THE PATIENT. POST PROCEDURE, A STENT REMOVAL WAS PERFORMED AND DURING THE PROCEDURE, THERE WAS DIFFICULTY IN REMOVING THE STENT AND IT WAS NOTICED THAT THE BLADDER COIL BROKE. THERE WAS NO INFORMATION ON WHAT DEVICE HAVE COMPLETED THE PROCEDURE. THE PATIENT HAD EXPERIENCED BLEEDING DURING THE PROCEDURE. NO OTHER COMPLICATIONS REPORTED.
Patient problems: Hemorrhage/Blood Loss/Bleeding
MAUDE report 22745836 ↗InjuryFeb 3, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CONTOUR URETERAL STENT WAS USED IN A STENT PLACEMENT PROCEDURE FOR STONE MANAGEMENT; LASER LITHOTRIPSY IN THE RIGHT URETER PERFORMED ON (B)(6) 2022. THE PATIENT UNDERWENT THE STUDY ON (B)(6) 2022, AS PART OF THE U0652 DOUBLE-J REGISTRY CLINICAL STUDY. POST PROCEDURE, ON (B)(6) 2022, A PLANNED STENT REMOVAL PROCEDURE WAS PERFORMED. THE STENT WAS NOT DIFFICULT TO REMOVE AND WAS REMOVED SUCCESSFULLY. PAIN CONTROL WAS REQUIRED. IT WAS REPORTED THAT ON (B)(6) 2022, THE PATIENT EXPERIENCED MILD IRRITATIVE MICTIONAL DISORDER AND WAS GIVEN A TREATMENT PLAN OF ALLERGIC INTERSTITIAL NEPHRITIS (AINS) DISCONTINUATION AND ONGOING DIURESIS ON (B)(6) 2022. THE MILD IRRITATIVE MICTIONAL DISORDER WAS REPORTED TO HAVE NOT BEEN RESOLVED. IN THE PHYSICIAN'S ASSESSMENT, THE RELATIONSHIP BETWEEN THE PROCEDURE AND THE EVENT IS POSSIBLY RELATED, AND THE RELATIONSHIP BETWEEN THE DEVICE AND THE EVENT IS POSSIBLY RELATED.
Patient problems: Micturition Urgency
MAUDE report 16300688 ↗
Other STENT, URETERAL devices
- Bard® InLay Optima® Ureteral Stent 788426C. R. Bard, Inc. · STENT, URETERAL1 recall100 reports
- Bard® InLay Optima® Ureteral Stent 788626C. R. Bard, Inc. · STENT, URETERAL122 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777626C. R. Bard, Inc. · STENT, URETERAL118 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777426C. R. Bard, Inc. · STENT, URETERAL108 reports
- Bard® InLay® Ureteral Stent 778626C. R. Bard, Inc. · STENT, URETERAL100 reports
- Percuflex™ Plus M0061752530Boston Scientific Corporation · STENT, URETERAL1 death99 reports
- Contour VL™ M0061801560Boston Scientific Corporation · STENT, URETERAL1 recall45 reports
- Polaris™ Ultra M0061921330Boston Scientific Corporation · STENT, URETERAL71 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page